Lpl Financial LLC Eli Lilly & CO Put Options Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 08, 2024	BUY	$772.14 - $960.02 $154,428 - $192,004	200 Added 13.33%	1,700 $1.51 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $1.05 Million - $1.32 Million	1,447 Added 2730.19%	1,500 $1.36 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $620,033 - $829,517	-1,047 Reduced 95.18%	53 $41,000
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $577,709 - $681,043	1,100 New	1,100 $641,000
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $2.03 Million - $2.28 Million	19,200 New	19,200 $2.22 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.